|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Agenus Inc.
| | | Phone: | (781) 674-4538 | Fax: | (781) 818-2985 | Year Established: | 1994 | Ticker: | AGEN | Exchange: | NASDAQ | Main Contact: | Ozer Baysal, CCO | | Other Contacts: | Michael Plater, PhD,, CBO Christine Klaskin, VP, Finance Jean-Marie Cuillerot, MD, CMO Alex Duncan, PhD, CTO & Head of Research Christian Cortis, PhD, Chief Strategy Officer Iman Barilero, PharmD, PhD, VP, Regulatory Science and Pharmacovigilance Jennifer Buell, Ph.D., COO Garo Armen, Ph.D., Chairman & CEO Karen Valentine, JD,, CLO Sunil Gupta, MD, VP, Regulatory & Pharmacovigilance Anna Wijatyk, MD, VP, Clinical Development
| | Company Description | Agenus (formerly Antigenics) is a biotechnology company working to develop treatments for cancers and infectious diseases. The company is focused on immunotherapeutic products based on strong platform technologies with multiple product candidates advancing through the clinic, including several product candidates that have advanced into late-stage clinical trials through corporate partners. Between Agenus and its partners, 18 programs are in clinical development. | |
|
|
|
|
|